The delivery of bioactive siRNAs targeting CSNK2A1 using fusogenic peptides has been shown to induce apoptosis in ovarian cancer cells in vitro and in vivo, suggesting a potential link between CSNK2A1 and mitochondrial function [60]. Here, CSNK2A1 is linked to ovarian carcinoma.